Part D drug prices grew faster than inflation
According to a report from Families USA, Medicare Part D drug prices grew almost four times faster than inflation from April 2006 to April 2007.
According to a report from Families USA, Medicare Part D drug prices grew almost four times faster than inflation from April 2006 to April 2007. The report found that the median Part D drug price for the top 15 drugs prescribed in the program increased on average 9.2%. The study noted that a year's supply of 200-mg Celebrex (celecoxib, Pfizer) rose in price from $946.44 to $1,033.32, an increase of 9.2%, while the 10-mg dose of Lexapro (escitalopram, Forest) increased 15%. The Families USA report examined changes in the lowest drug prices charged by the five largest insurers covering more than 65% of beneficiaries: UnitedHealthcare, Humana, WellPoint/Unicare, Member Health, and WellCare. Consumer health organization FamiliesUSA has been a frequent critic of the Medicare Part D program.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
